09.19.24 -- FDA Under Pressure To Respond To China-Related Clinical Trials Questions

Better understand how customizable laboratory services are revolutionizing oncology trials by enabling precision medicine and enhancing patient outcomes through flexible, innovative trial designs.

In this presentation, several clinical operations experts delve into the significance of meticulous contract examination when choosing an outsourcing partner.

Clinical trial audits are evolving. Learn how transparency and efficiency can revolutionize the process, saving time and providing a deeper understanding of operations.

Amid challenges during the COVID-19 pandemic, uncover how recruitment was completed in three countries for a Sweden-based pharmaceutical company's phase 2b study.

Learn how to leverage Early Access Programs (EAPs) in the EU to expedite market entry for innovative life science products. Gain insights into running successful EAPs, including crucial steps for France.

Witness how Biorasi’s India office has developed into a team of top performers with expertise across all vital components of clinical trial execution.

Navigate EU regulatory challenges and position your clinical development program for long-term success by reading our latest insights.

Discover how CROs and CDMOs tackle operational and regulatory challenges for pharmaceutical and biotechnology companies, and how this can be the key to study success or failure.

Here, speakers guide viewers through essential questions and real-world scenarios, helping to craft a successful Regulatory CMC roadmap throughout the clinical development lifecycle.